Literature DB >> 3886138

Role of sympathetic nerve activity in endotoxin induced hypotension in cats.

S Koyama, J W Manning.   

Abstract

Within 10 min of intravenous (iv) injection of E. coli endotoxin (1 mg X kg-1) in alpha-chloralose anaesthetised cats, mean blood pressure (MBP) fell significantly to 86% of the pre-endotoxin level. There followed a gradual decline in MBP, so that after 60 min MBP was depressed to 49% of the pre-endotoxin level. Preganglionic splanchnic nerve (PSN) activity decreased significantly before the rapid fall in MBP. There followed a gradual decrease in PSN activity coincident with the significant fall in MBP, so that 60 min after iv injection of E. coli endotoxin PSN activity fell to 40% of the pre-endotoxin level. Heart rate did not differ significantly from the pre-endotoxin level in the control group. However, the hypotension and the reduction of PSN activity following endotoxin were abolished by intracisternal (ic) pretreatment with phentolamine (0.5 mg X kg-1). The heart rate in this group increased significantly, by 15% at 10 min and was maintained until the end of the experiment. These results indicate that in E. coli endotoxin hypotension the blood pressure falls together with the reduction in sympathetic outflow; and suggests that stimulation of central alpha-adrenergic receptors leads to an inhibition of activity in brainstem sympathetic pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886138     DOI: 10.1093/cvr/19.1.32

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  2 in total

1.  The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray.

Authors:  William R Millington; M Sertac Yilmaz; Carlos Feleder
Journal:  Clin Exp Pharmacol Physiol       Date:  2016-06       Impact factor: 2.557

2.  Toward the Existence of a Sympathetic Neuroplasticity Adaptive Mechanism Influencing the Immune Response. A Hypothetical View-Part II.

Authors:  Emanuel Bottasso
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.